Literature DB >> 11750389

Enteric-coated mycophenolate sodium: results of two pivotal global multicenter trials.

D K Granger1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11750389     DOI： 10.1016/s0041-1345(01)02378-8

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

Review 1.  Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

Review 2.  Mycophenolate sodium delayed release: prevention of renal transplant rejection.

Authors:  Monique P Curran; Gillian M Keating
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 3.  Enteric-coated mycophenolate sodium: tolerability profile compared with mycophenolate mofetil.

Authors:  Matthias Behrend; Felix Braun
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 4.  Enteric-coated mycophenolate sodium: a review of its use in the prevention of renal transplant rejection.

Authors:  Mark Sanford; Gillian M Keating
Journal:  Drugs       Date:  2008       Impact factor: 9.546

5.  Mycophenolate sodium treatment in patients with primary Sjögren syndrome: a pilot trial.

Authors:  Peter Willeke; Bernhard Schlüter; Heidemarie Becker; Heiko Schotte; Wolfram Domschke; Markus Gaubitz
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.